Exousia Bio LMMY
OTC LMMY
$0.02 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Exousia Bio (LMMY) Cost of Revenue (2024 - 2026)

Updated

Exousia Bio's Cost of Revenue was $62,108 in fiscal Q3 2026 (quarter ended Feb 28, 2026), unchanged from the prior quarter.

Analysis

Exousia Bio (LMMY) Cost of Revenue (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Exousia Bio's Cost of Revenue was $131,467 through Feb 28, 2026; for FY2025 (ended May 31, 2025), it came in at $7,251, down 25.0% from FY2024.

  • In earlier fiscal years, Cost of Revenue was $9,667 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Bryn 945.00 Bn 945.00 Bn - -
2 Veeva Systems 44.24 Bn 16.49 Bn 695.95 Mn 232.01 Mn
3 Samsara 24.06 Bn 20.83 Bn 392.58 Mn 115.86 Mn
4 Toast 17.18 Bn 9.85 Bn 516.00 Mn 1.39 Bn
5 Ptc 15.95 Bn 14.76 Bn 490.47 Mn 109.58 Mn
6 Duolingo 13.49 Bn 8.67 Bn 216.74 Mn 81.71 Mn
7 Trimble 13.41 Bn 12.48 Bn 674.90 Mn 297.10 Mn
8 Manhattan Associates 11.90 Bn 10.90 Bn 168.33 Mn 129.46 Mn
9 Costar 11.09 Bn 5.06 Bn 728.00 Mn 197.00 Mn
10 Exousia Bio 335,295.33 335,295.33 -62,108.00 62,108.00
Historic Data

Historic Data

Download Data
DateValue
Feb 28, 2026 62,108.00
Nov 30, 2025 62,108.00
May 31, 2025 7,251.00
May 31, 2024 9,667.00
API Access

Exousia Bio Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=LMMY&period=max&api_key=YOUR_API_KEY